Skip to main content
Clare Sun, MD, Oncology, Bethesda, MD

ClareChui LingSunMD

Oncology Bethesda, MD

Hematologic Oncology

Physician

Dr. Sun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sun's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Loyola University Medical Center
    Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
  • University of British Columbia
    University of British ColumbiaClass of 2010

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2013 - 2025
  • DC State Medical License
    DC State Medical License 2014 - 2016
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells
    Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's T...
    Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib
    Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Spatial Genomic Heterogeneity in Chronic Lymphocytic Leukemia 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all